BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 22723318)

  • 1. Glucokinase activators AZD6370 and AZD1656 do not affect the central counterregulatory response to hypoglycemia in healthy males.
    Norjavaara E; Ericsson H; Sjöberg F; Leonsson-Zachrisson M; Sjöstrand M; Morrow LA; Hompesch M
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3319-25. PubMed ID: 22723318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of exogenously administered glucagon versus spontaneous endogenous counter-regulation on glycaemic recovery from insulin-induced hypoglycaemia in patients with type 2 diabetes treated with a novel glucokinase activator, AZD1656, and metformin.
    Krentz AJ; Morrow L; Petersson M; Norjavaara E; Hompesch M
    Diabetes Obes Metab; 2014 Nov; 16(11):1096-101. PubMed ID: 24909093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic effects of the oral glucokinase activator AZD6370 after single doses in healthy volunteers assessed with euglycaemic clamp.
    Sjöstrand M; Ericsson H; Hartford M; Norjavaara E; Eriksson JW
    Diabetes Obes Metab; 2013 Jan; 15(1):35-41. PubMed ID: 22958202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a hypothalamic-pituitary versus adrenal cortical effect of glycemic control on counterregulatory hormone responses to hypoglycemia in insulin-dependent diabetes mellitus.
    Kinsley BT; Simonson DC
    J Clin Endocrinol Metab; 1996 Feb; 81(2):684-91. PubMed ID: 8636289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulus specificity of defects in counterregulatory hormone secretion in insulin-dependent diabetes mellitus: effect of glycemic control.
    Kinsley BT; Widom B; Utzschneider K; Simonson DC
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1383-9. PubMed ID: 7962332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability, pharmacokinetics, and pharmacodynamics of the glucokinase activator AZD1656, after single ascending doses in healthy subjects during euglycemic clamp.
    Ericsson H; Röshammar D; Wollbratt M; Heijer M; Persson M; Ueda S; Leonsson-Zachrisson M; Norjavaara E
    Int J Clin Pharmacol Ther; 2012 Nov; 50(11):765-77. PubMed ID: 22943931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Counterregulatory responses to hypoglycemia in patients with glucokinase gene mutations.
    Guenat E; Seematter G; Philippe J; Temler E; Jequier E; Tappy L
    Diabetes Metab; 2000 Nov; 26(5):377-84. PubMed ID: 11119017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety, pharmacokinetics and pharmacodynamics of multiple-ascending doses of the novel glucokinase activator AZD1656 in patients with type 2 diabetes mellitus.
    Morrow LA; Leonsson-Zachrisson M; Ericsson H; Wollbratt M; Knutsson M; Hompesch M; Norjavaara E
    Diabetes Obes Metab; 2012 Dec; 14(12):1114-22. PubMed ID: 22775976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Troglitazone amplifies counterregulatory responses to hypoglycemia in nondiabetic subjects.
    Gabriely I; Wozniak R; Hawkins M; Shamoon H
    J Clin Endocrinol Metab; 2001 Feb; 86(2):521-8. PubMed ID: 11158003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of glimepiride and glyburide on glucose counterregulation and recovery from hypoglycemia.
    Szoke E; Gosmanov NR; Sinkin JC; Nihalani A; Fender AB; Cryer PE; Meyer C; Gerich JE
    Metabolism; 2006 Jan; 55(1):78-83. PubMed ID: 16324923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of differing durations of antecedent hypoglycemia on counterregulatory responses to subsequent hypoglycemia in normal humans.
    Davis SN; Mann S; Galassetti P; Neill RA; Tate D; Ertl AC; Costa F
    Diabetes; 2000 Nov; 49(11):1897-903. PubMed ID: 11078457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered responses to hypoglycemia of healthy elderly people.
    Meneilly GS; Cheung E; Tuokko H
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1341-8. PubMed ID: 8200936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the decrement in intraislet insulin for the glucagon response to hypoglycemia in humans.
    Gosmanov NR; Szoke E; Israelian Z; Smith T; Cryer PE; Gerich JE; Meyer C
    Diabetes Care; 2005 May; 28(5):1124-31. PubMed ID: 15855577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of duration of hypoglycemia on the hormonal counterregulatory response in normal subjects.
    Kerr D; MacDonald IA; Tattersall RB
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1118-22. PubMed ID: 2656734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender-related differences in counterregulatory responses to antecedent hypoglycemia in normal humans.
    Davis SN; Shavers C; Costa F
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2148-57. PubMed ID: 10852444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Counterregulatory hormone responses and symptoms during hypoglycaemia induced by porcine, human regular insulin, and Lys(B28), Pro(B29) human insulin analogue (insulin Lispro) in healthy male volunteers.
    Jacobs MA; Salobir B; Popp-Snijders C; Ader H; Heine RJ
    Diabet Med; 1997 Mar; 14(3):248-57. PubMed ID: 9088775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intravenous infusion of exenatide (synthetic exendin-4) on glucose-dependent insulin secretion and counterregulation during hypoglycemia.
    Degn KB; Brock B; Juhl CB; Djurhuus CB; Grubert J; Kim D; Han J; Taylor K; Fineman M; Schmitz O
    Diabetes; 2004 Sep; 53(9):2397-403. PubMed ID: 15331551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The glucokinase activator AZD6370 decreases fasting and postprandial glucose in type 2 diabetes mellitus patients with effects influenced by dosing regimen and food.
    Ericsson H; Sjöberg F; Heijer M; Dorani H; Johansson P; Wollbratt M; Norjavaara E
    Diabetes Res Clin Pract; 2012 Dec; 98(3):436-44. PubMed ID: 23010558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sleep loss alters basal metabolic hormone secretion and modulates the dynamic counterregulatory response to hypoglycemia.
    Schmid SM; Hallschmid M; Jauch-Chara K; Bandorf N; Born J; Schultes B
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3044-51. PubMed ID: 17519315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of an increase in plasma cortisol during hypoglycemia preserves subsequent counterregulatory responses.
    Davis SN; Shavers C; Davis B; Costa F
    J Clin Invest; 1997 Jul; 100(2):429-38. PubMed ID: 9218521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.